EUCROF25 Speakers
EUCROF25 brings together leading industry experts to deliver an extensive array of presentations, expert panel discussions, interactive workshops, and breakout sessions. Speakers will share their vast knowledge and experiences on the multifaceted nature of clinical research, covering essential topics such as regulatory changes, clinical trial technologies, quality assurance, data management, and patient-centric approaches.
Meet the EUCROF25 Speakers below.
Keynote Speakers
Emer Cooke
The European Medicines Agency
Monique Al
Central Committee on Research Involving Human Subjects, The Netherlands
Richelle Flanagan
My Moves Matter
Breakout Session Speakers
Anna Titkova
Pratia
Eleanor McLaurin
Medidata, Dassault Systèmes
Honz Slipka
Certara
Kevin Macho Gamboa
Medidata, Dassault Systèmes
Maria Veleva
Velev Consulting Ltd
Paul O'Donohoe
Medidata, Dassault Systèmes
Annika Baan
CTU oncology Sahlgrenska Comprehensive Cancer Center Sweden
Catherine Jervis
MRN
Erik Vollebregt
Axon
Inez Sroda
Nestlé Research
Łukasz Izbicki
ClinicalTrials.eu
Matt Feldman
InTheDistance Media, LLC
Sabina Hoekstra van den Bosch
TUV SUD
Atiye Nazari
Nestlé Research
Cécile van der Heijden
Axon Lawyers
Geert Briers
Deltaclinical
Iwona Tongbhoyai
Futuremeds LTD
Łukasz Wiech
ClinicalTrials.eu
Nicholas Brooke
Synergist
Szilvia Harsányi
Research Professionals Ltd.
Audrey Van Scharen
Belgian Association of Research Ethics Committees
Charlene Muscat
UCB Pharma
Gert Bos
Qserve Group
Joana Claverol Torres
Sant Joan de Déu Research Foundation
Majd Mirza
Viedoc Technologies
Nicholas Thevenet
Euraxi Pharma
Tanja A.M. Hoffman
TNJ Life Sciences Consultancy
Begonya Nafria Escalera
Sant Joan de Déu Research Foundation
Donatella Ballerini
Montrium
Graham Wylie
MRN
Karen Gabriels
Archer Research
Manan Trivedi
UCB Pharma
Novilyn Villanueva
Region 1 Medical Center
Valerie Nadugo Tumaliuan
Region 1 Medical Center
Programme
The EUCROF25 programme aims to further enrich the dialogue and cooperation across the spectrum of clinical research sectors. Sessions will reflect the current state of clinical research while also exploring the pressing challenges and exciting opportunities that lie ahead.